Ownership history in Logos Global Management LP · 23 quarters on record
This page tracks every 13F SEC filing in which Logos Global Management LP reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 1,000,000 | — | 0% | 1.52% | $25.1M | $25.12 |
| 2025 Q3 | UNCHANGED | 1,000,000 | — | 0% | 2.03% | $22.6M | $22.63 |
| 2025 Q2 | ADDED | 1,000,000 | +500,000 | +100.0% | 1.92% | $17.3M | $17.31 |
| 2024 Q4 | REDUCED | 500,000 | -500,000 | -50.0% | 1.87% | $16.0M | $31.91 |
| 2024 Q3 | ADDED | 1,000,000 | +600,000 | +150.0% | 3.11% | $28.8M | $28.84 |
| 2024 Q2 | REDUCED | 400,000 | -1,600,000 | -80.0% | 1.25% | $15.3M | $38.36 |
| 2024 Q2 | ADDED | 2,000,000 | +1,200,000 | +150.0% | 6.23% | $76.7M | $38.36 |
| 2024 Q1 | REDUCED | 800,000 | -150,000 | -15.8% | 3.81% | $47.0M | $58.78 |
| 2023 Q4 | REDUCED | 950,000 | -50,000 | -5.0% | 5.31% | $56.9M | $59.86 |
| 2023 Q4 | ADDED | 1,000,000 | +350,000 | +53.8% | 5.59% | $59.9M | $59.86 |
As of 2025 Q4 — sorted by position size